Giovanni Recordati is chairman and CEO of the Recordati Group, a European pharmaceutical group employing more than 2,800 workers in the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, it operates throughout Western Europe and has a growing presence in the new markets of Central and Eastern Europe. Recordati sat down with Modern Russia to discuss the company’s interest in the Russian pharmaceutical industry.